Executive Director, Asset Team Lead
Core
Drive strategic positioning and decisioning for small molecule clinical programs in oncology and immunology/inflammation, translating scientific complexity into competitive clarity to advance transformative medicines.
Role type
Senior strategic asset lead (executive director)
Builds
Strategic asset portfolios and go/no-go decisions for oncology and I&I programs
Domain
Biotech/Pharma, Oncology, Immunology/Inflammation, AI-driven drug discovery
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
Asset-level strategic leadership, small molecule therapeutic development, competitive positioning, biomarker strategy, patient segmentation, portfolio prioritization, cross-functional resource allocation, executive presence, financial acumen
Preferred skills
Rare disease expertise, experience with computational approaches and data-driven platforms
Technologies
Recursion OS, ClinTech, AI-powered platforms, predictive modeling, RWE integration
Responsibilities
Define and drive asset strategy integrating competitive positioning and mechanistic differentiation; Translate proprietary data and computational insights into strategic advantages; Develop and pressure-test competitive narratives for leadership and investor communications; Partner with functional leaders to align resource allocation with strategic conviction; Propagate the Recursion mindset to advance assets for patients with unmet need
Seniority
Executive Director, senior strategic partner
